Pages that link to "Q27851948"
Jump to navigation
Jump to search
The following pages link to CDKN2A (p16) promoter hypermethylation influences the outcome in young lung cancer patients (Q27851948):
Displaying 11 items.
- Methylated circulating tumor DNA in blood: power in cancer prognosis and response (Q26772077) (← links)
- CIViC database (Q27612411) (← links)
- CDKN2A Promoter Hypermethylation (Q27925513) (← links)
- Clinical significance of DAPK promoter hypermethylation in lung cancer: a meta-analysis (Q35229048) (← links)
- Colorectal cancer DNA methylation patterns from patients in Manaus, Brazil (Q36053988) (← links)
- Epigenetic research in cancer epidemiology: trends, opportunities, and challenges (Q37587537) (← links)
- Risk factors for bone metastasis in completely resected non-small-cell lung cancer (Q38793159) (← links)
- High LET (56)Fe ion irradiation induces tissue-specific changes in DNA methylation in the mouse (Q45214127) (← links)
- Recent advances in epigenomics in NSCLC: real-time detection and therapeutic implications. (Q53048458) (← links)
- Tyrosine Kinase Inhibitor Imatinib Mesylate Alters DMBA-Induced Early Onco/Suppressor Gene Expression with Tissue-Specificity in Mice (Q64265033) (← links)
- Distinctive targetable genotypes of younger patients with lung adenocarcinoma: a cBioPortal for cancer genomics data base analysis (Q90594908) (← links)